2. Gene
  3. CAPS - calcyphosine Gene

CAPS - calcyphosine Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens

Also known as CAPS1

Gene ID: 828 | Gene type: protein coding

About CAPS

Cytogenetic location: 19p13.3 Genomic coordinates (GRCh38): 19:5,914,254-5,916,211 (from NCBI)

This gene has 5 transcripts (splice variants), 98 orthologues and 5 paralogues. Broad expression in lung (RPKM 22.4), endometrium (RPKM 13.8) and 21 other tissues.

Summary

This gene encodes a calcium-binding protein, which may play a role in the regulation of ion transport. A similar protein was first described as a potentially important regulatory protein in the dog thyroid and was termed as R2D5 antigen in rabbit. Alternative splicing of this gene generates two transcript variants. [provided by RefSeq, Jul 2008]

CAPS Products(2)

mRNA Protein Name
NM_004058.5 NP_004049.3 calcyphosin isoform a
NM_080590.4 NP_542157.3 calcyphosin isoform b

CAPS Protein Structure

EF-hand_7

EF-hand_7: EF-hand domain pair (26 - 85)

EF-hand_7

EF-hand_7: EF-hand domain pair (100 - 166)

  • 0
  • 100
  • 189 a.a.
Protein Preferred Names Protein Names

calcyphosin

calcyphosine 1

Related Diseases

Diseases Alias
Clonorchiasis

Oriental Liver Fluke Disease

Clonorchis Liver Infection

Clonorchiosis

Chinese Liver Fluke Disease

Hepatic Distomiasis Due To Clonorchis Sinensis

Infection Due To Clonorchis Sinensis

Hepatic Distomiasis

Hepatic Distomatosis

Chinese Liver Fluke Disorder

Oriental Liver Fluke Disorder

Clonorchis Infestation

Chinese Liver Fluke Infestation

Liver Fluke Disease Due To Clonorchis Sinensis

Oriental Liver Fluke Infestation
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Approval
Bioactive Molecules (5)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-109025A Baloxavir Inhibitor 99.68% Unkown
HY-109025 Baloxavir marboxil Inhibitor 99.92% Unkown
HY-17452A Cefditoren (Pivoxil) Inhibitor 99.31% Unkown
HY-17452 Cefditoren sodium Inhibitor 99.70% Unkown
HY-116229 Gemifloxacin Inhibitor / Unkown
Clinical Phase
Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-D0869 CAPS 99.61% Phase 4
HY-105172 TT-232 Agonist 98.96% Phase 2
Pre-clinical Phase
Bioactive Molecules (96)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-N0086 N6-Methyladenosine Inhibitor 99.07% Unkown
HY-139553 Zunsemetinib Inhibitor 99.37% Unkown
HY-14427 4E1RCat Inhibitor 98.99% Unkown
HY-153040 HPPE Inhibitor 99.81% Unkown
HY-15523 Braco-19 Inhibitor 99.51% Unkown
HY-148771 MTX-23 99.90% Unkown
HY-15523A Braco-19 trihydrochloride Inhibitor 99.73% Unkown
HY-139100B N7-Methyl-guanosine-5'-triphosphate-5'-adenosine diammonium 98.82% Unkown
HY-18684 SIBA Inhibitor 99.66% Unkown
HY-14956 Nemonoxacin Inhibitor 99.80% Unkown
HY-21586B 7-Methyl-guanosine-5'-triphosphate sodium 99.69% Unkown
HY-N6772 Cytochalasin E Inhibitor 99.90% Unkown
HY-145973A 3'OMe-m7GpppAmpG ammonium Modulator ≥99.0% Unkown
HY-N2362 DL-Alanine ≥98.0% Unkown
HY-139100 N7-Methyl-guanosine-5'-triphosphate-5'-adenosine / Unkown
HY-141472 7-Methylguanosine 5'-diphosphate sodium ≥97.0% Unkown
HY-145974A m7GpppAmpG ammonium Modulator ≥99.0% Unkown
HY-D0948 Celestine Blue 66.00% Unkown
HY-N0086S N6-Methyladenosine-d3 99.97% Unkown
HY-N2362S1 DL-Alanine-13C-3 ≥98.0% Unkown
HY-W441004 DSPE-Thiol ≥90.0% Unkown
HY-W751835 Baloxavir-d4 99.27% Unkown
HY-139101A Guanosine 5'-triphosphate-5'-adenosine triammonium / Unkown
HY-N2362S2 DL-Alanine-d3 ≥98.0% Unkown
HY-132894 Cap-dependent endonuclease-IN-1 / Unkown
HY-109025AS Baloxavir-d5 Inhibitor / Unkown
HY-12914 V116517 Antagonist / Unkown
HY-133887 Methotrexate α-tert-butyl ester Inhibitor ≥96.0% Unkown
HY-135517 RXP470.1 Inhibitor / Unkown
HY-139098 7-Methyl-diguanosine triphosphate / Unkown
HY-139553A (R)-Zunsemetinib 97.84% Unkown
HY-143743 Cap-dependent endonuclease-IN-2 / Unkown
HY-143744 Cap-dependent endonuclease-IN-3 / Unkown
HY-143747 Cap-dependent endonuclease-IN-5 / Unkown
HY-143749 Cap-dependent endonuclease-IN-6 Inhibitor / Unkown
HY-143750 Cap-dependent endonuclease-IN-7 / Unkown
HY-143752 Cap-dependent endonuclease-IN-8 / Unkown
HY-143755 Cap-dependent endonuclease-IN-9 / Unkown
HY-143757 Cap-dependent endonuclease-IN-10 / Unkown
HY-143762 Cap-dependent endonuclease-IN-12 Inhibitor / Unkown
HY-143766 Cap-dependent endonuclease-IN-13 / Unkown
HY-143768 Cap-dependent endonuclease-IN-14 / Unkown
HY-143769 Cap-dependent endonuclease-IN-15 / Unkown
HY-143770 Cap-dependent endonuclease-IN-16 / Unkown
HY-143771 Cap-dependent endonuclease-IN-17 Inhibitor / Unkown
HY-143775 Cap-dependent endonuclease-IN-20 Inhibitor / Unkown
HY-143776 Cap-dependent endonuclease-IN-22 Inhibitor / Unkown
HY-143781 Cap-dependent endonuclease-IN-26 Inhibitor / Unkown
HY-144065 Cap-dependent endonuclease-IN-19 / Unkown
HY-144066 Cap-dependent endonuclease-IN-21 / Unkown
HY-144067 Cap-dependent endonuclease-IN-23 / Unkown
HY-144068 Cap-dependent endonuclease-IN-25 / Unkown
HY-145538 2'-Deoxyguanosine 5'-monophosphate disodium hydrate / Unkown
HY-145913 m7GpppApG / Unkown
HY-145969 β-S-ARCA / Unkown
HY-145973 3'OMe-m7GpppAmpG Modulator / Unkown
HY-145975 m7Gpppm6AmpG / Unkown
HY-145977 m7GpppGmpG Modulator / Unkown
HY-145977A m7GpppGmpG ammonium Modulator / Unkown
HY-145979 m7GpppUmpG / Unkown
HY-145980 m7GpppUpG / Unkown
HY-145981 m7GpppCpG / Unkown
HY-145982 m7GpppCmpG / Unkown
HY-147339 M7G(3'-OMe-5')pppA(2'-OMe) / Unkown
HY-147730 HDAC6-IN-8 / Unkown
HY-149263 HAA-09 Inhibitor / Unkown
HY-150144 Uracil-m7GpppAmpG ammonium Modulator / Unkown
HY-153570 Influenza virus-IN-7 Inhibitor / Unkown
HY-155337 eIF4E-IN-6 / Unkown
HY-155676 eIF4E-IN-5 Inhibitor / Unkown
HY-157339 MMT-2'-O-Methyl adenosine (n-bz) CED phosphoramidite / Unkown
HY-162242 Cap-dependent endonuclease-IN-27 Inhibitor / Unkown
HY-163498 NLRP3-IN-37 Inhibitor / Unkown
HY-D0869S 3-(Cyclohexylamino)-1-propanesulfonic Acid-d17 / Unkown
HY-E70080 Vaccinia virus capping enzyme / Unkown
HY-E70081 mRNA Cap 2'-O-methyltransferase / Unkown
HY-N0086S2 N6-Methyladenosine-13C4 Inhibitor / Unkown
HY-N0086S3 N6-Methyladenosine-13C3 Inhibitor / Unkown
HY-N2362S DL-Alanine-13C-1 ≥98.0% Unkown
HY-N2362S5 DL-Alanine-15N / Unkown
HY-N7647 Methyl brevifolincarboxylate Inhibitor / Unkown
HY-P2458 CAP18 (rabbit) Inhibitor / Unkown
HY-P3911 CAP 37 (20-44) / Unkown
HY-RS01880 CAP1 Human Pre-designed siRNA Set A / Unkown
HY-RS01881 CAP2 Human Pre-designed siRNA Set A / Unkown
HY-RS01899 CAPS Human Pre-designed siRNA Set A / Unkown
HY-RS01900 CAPS2 Human Pre-designed siRNA Set A / Unkown
HY-W423489 SARS-CoV-2-IN-76 Inhibitor / Unkown
HY-139101 Guanosine 5'-triphosphate-5'-adenosine / Unkown
HY-145974 m7GpppAmpG Modulator / Unkown
HY-145975A m7Gpppm6AmpG ammonium 98.84% Unkown
HY-145976 m7GpppGpG / Unkown
HY-151829 Fmoc-L-Asn(EDA-N3)-OH / Unkown
HY-157504 2′-O-Methyl-5′-O-phosphonoadenylyl-(3′→5′)-guanosine TEA / Unkown
HY-W028714 2,3-Diphenylquinoxaline-6-carboxylic acid / Unkown
HY-W441002 DSPE-succinic acid / Unkown

Orthologs Information

Species Symbol Source ID
Rattus norvegicus CAPS RGD RGD:41237504
Canis familiaris CAPS VGNC VGNC:54265
Macaca mulatta CAPS VGNC VGNC:108145
Bos taurus CAPS VGNC VGNC:26753
Others CAPS NCBI